95 related articles for article (PubMed ID: 17638300)
1. Cell-specific expression of neutral glycosphingolipids in vertebrate brain: immunochemical localization of 3-O-acetyl-sphingosine-series glycolipid(s) in myelin and oligodendrocytes.
Dasgupta S; Bhat NR; Spicer SS; Hogan EL; Furuya S; Hirabayashi Y
J Neurosci Res; 2007 Oct; 85(13):2856-62. PubMed ID: 17638300
[TBL] [Abstract][Full Text] [Related]
2. Developmental and topographic expression of neutral glycosphingolipids in vertebrate brain.
Dasgupta S; Hogan EL
Indian J Biochem Biophys; 1997; 34(1-2):166-9. PubMed ID: 9343945
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts.
Bennion B; Dasgupta S; Hogan EL; Levery SB
J Mass Spectrom; 2007 May; 42(5):598-620. PubMed ID: 17370250
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of gangliotetraosylceramide (GA1) in normal human brain and its developmental change.
Dasgupta S; Hogan EL
Indian J Biochem Biophys; 1993 Dec; 30(6):341-5. PubMed ID: 8005616
[TBL] [Abstract][Full Text] [Related]
5. TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes.
Hoffmann A; Grimm C; Kraft R; Goldbaum O; Wrede A; Nolte C; Hanisch UK; Richter-Landsberg C; Brück W; Kettenmann H; Harteneck C
J Neurochem; 2010 Aug; 114(3):654-65. PubMed ID: 20163522
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain.
Moldrich RX; Lainé J; Visel A; Beart PM; Laffaire J; Rossier J; Potier MC
Neuroscience; 2008 Jul; 154(4):1255-66. PubMed ID: 18541381
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and immunohistochemical localization of IV(4)GalNAcGgOse(4)Cer: a naturally occurring novel neutral glycosphingolipid in bovine brain.
Dasgupta S; van Halbeek H; Spicer S; Hogan EL
Glycobiology; 2000 Jan; 10(1):1-9. PubMed ID: 10570218
[TBL] [Abstract][Full Text] [Related]
8. Expression of pannexin2 protein in healthy and ischemized brain of adult rats.
Zappalà A; Li Volti G; Serapide MF; Pellitteri R; Falchi M; La Delia F; Cicirata V; Cicirata F
Neuroscience; 2007 Sep; 148(3):653-67. PubMed ID: 17692470
[TBL] [Abstract][Full Text] [Related]
9. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia.
Melani A; Cipriani S; Vannucchi MG; Nosi D; Donati C; Bruni P; Giovannini MG; Pedata F
Brain; 2009 Jun; 132(Pt 6):1480-95. PubMed ID: 19359287
[TBL] [Abstract][Full Text] [Related]
10. Investigations on myelination in vitro. III. Ultrastructural, biochemical, and immunohistochemical studies in cultures of dissociated brain cells from embryonic mice.
Sarliève LL; Delaunoy JP; Dierich A; Ebel A; Fabre M; Mandel P; Rebel G; Vincendon G; Wintzerith M; Yusufi AN
J Neurosci Res; 1981; 6(5):659-83. PubMed ID: 6172594
[No Abstract] [Full Text] [Related]
11. The inhibitor of DNA binding 2 is mainly expressed in oligodendrocyte lineage cells in adult rat brain.
Chen XS; Zhou DS; Yao ZX
Neurosci Lett; 2007 Nov; 428(2-3):93-8. PubMed ID: 18029094
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody Rip specifically recognizes 2',3'-cyclic nucleotide 3'-phosphodiesterase in oligodendrocytes.
Watanabe M; Sakurai Y; Ichinose T; Aikawa Y; Kotani M; Itoh K
J Neurosci Res; 2006 Aug; 84(3):525-33. PubMed ID: 16786579
[TBL] [Abstract][Full Text] [Related]
13. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
14. Selective expression of LDLR and VLDLR in myelinating oligodendrocytes.
Zhao S; Hu X; Park J; Zhu Y; Zhu Q; Li H; Luo C; Han R; Cooper N; Qiu M
Dev Dyn; 2007 Sep; 236(9):2708-12. PubMed ID: 17685481
[TBL] [Abstract][Full Text] [Related]
15. Type III neuregulin-1 promotes oligodendrocyte myelination.
Taveggia C; Thaker P; Petrylak A; Caporaso GL; Toews A; Falls DL; Einheber S; Salzer JL
Glia; 2008 Feb; 56(3):284-93. PubMed ID: 18080294
[TBL] [Abstract][Full Text] [Related]
16. Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid.
Podbielska M; Dasgupta S; Levery SB; Tourtellotte WW; Annuk H; Moran AP; Hogan EL
J Lipid Res; 2010 Jun; 51(6):1394-406. PubMed ID: 20154333
[TBL] [Abstract][Full Text] [Related]
17. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
Mothe AJ; Tator CH
Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
[TBL] [Abstract][Full Text] [Related]
18. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair.
Lecca D; Trincavelli ML; Gelosa P; Sironi L; Ciana P; Fumagalli M; Villa G; Verderio C; Grumelli C; Guerrini U; Tremoli E; Rosa P; Cuboni S; Martini C; Buffo A; Cimino M; Abbracchio MP
PLoS One; 2008; 3(10):e3579. PubMed ID: 18974869
[TBL] [Abstract][Full Text] [Related]
19. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
Nunzi MG; Mugnaini E
Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
[TBL] [Abstract][Full Text] [Related]
20. Bimodal occurrence of aspartoacylase in myelin and cytosol of brain.
Wang J; Matalon R; Bhatia G; Wu G; Li H; Liu T; Lu ZH; Ledeen RW
J Neurochem; 2007 Apr; 101(2):448-57. PubMed ID: 17254025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]